Clinical Trial Update: Protection Response to Cellular Stress in BPAN's Patient Study

View source ↗

Summary

The document reports the completion of a BPAN patient study investigating protection against cellular stress in individuals carrying pathogenic WDR45 variants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-propeller Protein-associated Neurodegeneration

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Children and Adults With BPAN Carrying Pathogenic Variants of WDR45 | Status: COMPLETED